Search by Topic

Join our mailing list!

Loading...

Thanks! You've been successfully signed up for the BTU newsletter!

September 21, 2012

Microbubbles deliver clot-busting drug during transport

Business Wire

CHICAGO — Physicians announced today that tiny microbubbles are being used to more effectively deliver a blood clot busting drug to patients while they are in the ambulance during acute heart attack.

"Time is muscle," said Dr. Otto Kamp from VU University Medical Center in the Netherlands, stating that the quicker you deliver therapy the more heart muscle you will save.

Liquid suspensions of tiny gas microbubbles have traditionally been used as a diagnostic imaging tool. The microbubble suspensions are routinely used as ultrasound contrast agents to improve the clarity and reliability of an ultrasound image without exposing patients to ionizing radiation. The microbubbles are about a third the size of a red blood cell and, when they are injected into a patient's arm vein, they improve the clarity and accuracy of diagnostic ultrasound exams. The microbubbles are expelled from the body within minutes.

Dr. Kamp's findings move microbubbles from a diagnostic imaging use to an exciting therapeutic application. He used microbubblesalong with TPA, a drug that busts blood clots.When theinjected microbubbles reached the clot, increased ultrasound frequencies were applied to cause the microbubbles to burst. The burst bubbles create tiny holes in the clot,allowing the drug to workmore effectively in itstargeted location.

"This permits a lower and safer dose of TPA with reduced side effects, especially hemorrhage and stroke," according to Dr. Kamp. "This also permits increased doses of TPA and improves the efficiency of this therapy."

Steve Feinstein, a Rush University cardiologist and ICUS Co-president, said the findings demonstrate the vast potential benefits of using microbubble ultrasound contrast agents as a platform for delivering a range of drugs and genes to specific organ systems and tumors.

"Considerable work is underway showing that microbubbles may be useful in delivering cancer drugs, diabetes drugs, and genes that increase HDL — good cholesterol — to targeted sites throughout the body," he said. "Dr. Kamp's work is especially exciting because it now showshow a related technique works in patients."

The Netherlandsresearch was announced at the 27th Annual Advances in Contrast Ultrasound ICUS Bubble Conference, a gathering of physcians and scientists around the world in the fields of cardiology, radiology, vascular medicine, gastro-intestinal medicine, oncology, and other medical specialties.

Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved.
Terms and Conditions Privacy Policy
Copyright 2012 Business Wire, Inc.


Search